ARK™ Ethyl Glucuronide Control is intended for use in quality control of the ARK
ARK™ Ethyl Glucuronide Control is intended for use in quality control of the ARK™ Ethyl Glucuronide Assay.
ARK™ Fentanyl Negative Calibrator is intended for use in the calibration of the
ARK™ Fentanyl Negative Calibrator is intended for use in the calibration of the ARK™ Fentanyl Assay.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
ARK™ Methylphenidate Metabolite Calibrator is intended for use in calibration of
ARK™ Methylphenidate Metabolite Calibrator is intended for use in calibration of the ARK™ Methylphenidate Metabolite Assay.
ARK™ Ethyl Glucuronide Control is intended for use in quality control of the ARK
ARK™ Ethyl Glucuronide Control is intended for use in quality control of the ARK™ Ethyl Glucuronide Assay.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qu
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semi-quantitative and determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qu
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semi-quantitative and determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.
The ARK™ Lacosamide Assay is a homogeneous enzyme immunoassay intended for the
The ARK™ Lacosamide Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of lacosamide in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of lacosamide to help ensure appropriate therapy.
The ARK™ Oxcarbazepine Metabolite Control is an assayed quality control material
The ARK™ Oxcarbazepine Metabolite Control is an assayed quality control material intended for use in quality control of the ARK™ Oxcarbazepine Metabolite Assay.
The ARK™ Oxcarbazepine Metabolite Assay is a homogeneous enzyme immunoassay inte
The ARK™ Oxcarbazepine Metabolite Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.
ARK™Pregabalin Urine Control is intended for use in quality control of the ARK™P
ARK™Pregabalin Urine Control is intended for use in quality control of the ARK™Pregabalin Urine Assay.
The ARK Methotrexate Assay c-Pack is a homogeneous enzyme immunoassay intended f
The ARK Methotrexate Assay c-Pack is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.
The ARK™ Methotrexate Dilution Buffer is intended for dilution of specimens cont
The ARK™ Methotrexate Dilution Buffer is intended for dilution of specimens containing high concentrations of methotrexate for the ARK™ Methotrexate Assay. Its composition is equivalent to the Calibrator A (zero) of ARK™ Methotrexate Calibrator 5026-0002-00.
The ARK Methotrexate Assay is a homogeneous enzyme immunoassay intended for the
The ARK Methotrexate Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.
The ARK™ Gabapentin Assay is a homogeneous enzyme immunoassay intended for the q
The ARK™ Gabapentin Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of gabapentin in human serum or plasma on automated clinical chemistry analyzers. Gabapentin concentrations can be used as an aid in management of patients treated with gabapentin.
The ARK Methotrexate Assay c-Pack (cobas c pack green reagent packs) is a homoge
The ARK Methotrexate Assay c-Pack (cobas c pack green reagent packs) is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.
The ARK™ Fentanyl II Assay is a homogeneous enzyme immunoassay intended for the
The ARK™ Fentanyl II Assay is a homogeneous enzyme immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 0.5 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.
The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determin
The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PINACA and their metabolites in human urine at a cutoff concentration of 5 ng/mL.
The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determin
The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PINACA and their metabolites in human urine at a cutoff concentration of 5 ng/mL.
ARK™ UR-144/JWH-018 Negative Calibrator is intended for use in calibration of th
ARK™ UR-144/JWH-018 Negative Calibrator is intended for use in calibration of the ARK™ UR-144/JWH-018 Assay.
ARK™ Meperidine Control is intended for use in quality control of the ARK™ Meper
ARK™ Meperidine Control is intended for use in quality control of the ARK™ Meperidine Assay.
ARK™ Ketamine Cutoff Calibrator is intended for use in calibration of the ARK™ K
ARK™ Ketamine Cutoff Calibrator is intended for use in calibration of the ARK™ Ketamine Assay.
The ARK™ Tramadol Assay is intended for the qualitative and/or semiquantitative
The ARK™ Tramadol Assay is intended for the qualitative and/or semiquantitative determination of tramadol in human urine at a cutoff concentration of 100ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers.
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qu
The ARK™ Fentanyl Assay is a homogeneous enzyme immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 0.5 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.
ARK™ Ethyl Glucuronide 500 Cutoff Calibrator is intended for use in calibration
ARK™ Ethyl Glucuronide 500 Cutoff Calibrator is intended for use in calibration of the ARK Ethyl Glucuronide Assay.
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquanti
The ARK™ Ethyl Glucuronide Assay is intended for the qualitative and semiquantitative determination of ethyl glucuronide in human urine at cutoff concentrations of 500 ng/mL and 1000 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting ethyl glucuronide in urine and is designated for professional use on automated clinical chemistry analyzers.
ARK™ Ethyl Glucuronide 500 Cutoff Calibrator is intended for use in calibration
ARK™ Ethyl Glucuronide 500 Cutoff Calibrator is intended for use in calibration of the ARK Ethyl Glucuronide Assay.
The ARK™ Methotrexate Control consists of a three-level set used for quality con
The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level calibration range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L and 0.80umol/L.
The ARK™ Methotrexate Control consists of a three-level set used for quality con
The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level high range set). The controls consist of a synthetic protein matrix and the levels are 5 umol/L, 50 umol/L and 500 umol/L.)
The ARK™ Methotrexate Control consists of a three-level set used for quality con
The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level calibration range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L and 0.80umol/L.
The ARK™ Methotrexate Control consists of a six-level set used for quality contr
The ARK™ Methotrexate Control consists of a six-level set used for quality control of the assay (tri-level calibration range set and tri-level high range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L, 0.80umol/L, 5 umol/L, 50 umol/L and 500 umol/L.
The ARK™ Zonisamide Control is intended for use in quality control of the ARK
The ARK™ Zonisamide Control is intended for use in quality control of the ARK™Zonisamide Assay.
The ARK™ Gabapentin Calibrator is intended for use in calibration of the ARK™
The ARK™ Gabapentin Calibrator is intended for use in calibration of the ARK™ Gabapentin Assay.
The ARK™ Levetiracetam Calibrator is intended for use in calibration of the A
The ARK™ Levetiracetam Calibrator is intended for use in calibration of the ARK™ Levetiracetam Assay.
The ARK™ Lamotrigine Calibrator is intended for use in calibration of the ARK
The ARK™ Lamotrigine Calibrator is intended for use in calibration of the ARK™ Lamotrigine Assay.
DRI™ Fentanyl II Control (Thermo Fisher) is intended for use in quality control
DRI™ Fentanyl II Control (Thermo Fisher) is intended for use in quality control of the DRI™ Fentanyl II Assay.
ARK™ HS Benzodiazepine II 75/125ng/mL Control is intended for use in quality con
ARK™ HS Benzodiazepine II 75/125ng/mL Control is intended for use in quality control of the ARK™ HS Benzodiazepine II Assay.
ARK™Pregabalin II Control is intended for use in quality control of the ARK™Preg
ARK™Pregabalin II Control is intended for use in quality control of the ARK™Pregabalin II Assay.
ARK™ Meperidine Negative Calibrator is intended for use in calibration of the AR
ARK™ Meperidine Negative Calibrator is intended for use in calibration of the ARK™ Meperidine Assay.
The eScreen eCup® is a patented urine collection device designed to allow for ra
The eScreen eCup® is a patented urine collection device designed to allow for rapid, under-seal screening. The eCup’s lid contains several embedded reagent test strips that are sensitive to the five-test SAMHSA (Substance Abuse and Mental Health Services Administration) profile cutoff levels. The lid’s test strips also detect and provide adulteration panels for pH, creatinine, and nitrites. When the eCup is placed into the eReader device, its test strips are digitally screened for the presence or absence of drugs of abuse.
The xCupTM for use with the xReaderTM is for in vitro diagnostic use and is int
The xCupTM for use with the xReaderTM is for in vitro diagnostic use and is intended for prescription use in laboratories, point-of-care and workplaces by trained users. The test is not intended for over-the-counter use. The test device cannot be read visually and must be used with the xReaderTM. The xCupTM qualitatively detects drug classes in human urine at the following cut-off concentrations:Amphetamines at 500 ng/ml; Barbiturates at 300 ng/mL; Benzodiazepines at 300 ng/mL; Cocaine at 150 ng/mL; Methamphetamines at 500 ng/mL; Methadone at 300 ng/mL; Morphine at 300 ng/mL and 2000 ng/mL; Oxycodone at 100 ng/mL; Phencyclidine at 25 ng/mL; and Marijuana at 50 ng/mL.Configurations of the xCupTM may consist of any combination of the listed drug analytes. The xCupTM only provides a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography / mass spectrometry (GC/MS), high performance liquid chromatography (HPLC) or liquid chromatography / tandem mass spectrometry (LC/MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained.
A rapid, one step screening test for the simultaneous, qualitative detection of
A rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine.